Aerie begins trial of sustained release drug for retinal disease

August 20, 2019
Aerie Pharmaceuticals has initiated a clinical trial of AR-13503, a sustained release implant, for treatment of neovascular age-related macular…

Meeting NewsVideo

VIDEO: Analytical data may help predict, prevent vision loss

August 19, 2019
CHICAGO — At the American Society of Retina Specialists meeting, Daniela Ferrara, MD, MSc, PhD, discusses the use of advanced analytics in the…

Eylea prefilled syringe approval leads weekly ophthalmology headlines

August 18, 2019
Here are some of the recent top stories on

Five FDA ophthalmology updates you might have missed

August 17, 2019
The FDA has issued multiple approvals and denials of drugs, formulations and devices over the past month. Here are five recent ophthalmology-related…

Meeting NewsVideo

VIDEO: Steroid challenge predictive of IOP lowering in eyes with fluocinolone implants

August 16, 2019
CHICAGO — At the American Society of Retina Specialists meeting, Victor H. Gonzalez, MD, summarizes a trial on the real-world use of Iluvien…

Seenu Hariprasad, MD, receives ASRS teaching, mentorship award

August 16, 2019
Seenu M. Hariprasad, MD, was presented with the Crystal Apple Award by the ASRS Early Career Section for excellence in teaching and mentorship…

Meeting NewsVideo

VIDEO: Faricimab shows long-term durability potential as DME treatment

August 16, 2019
CHICAGO — At the American Society of Retina Specialists meeting, Vrinda S. Hershberger, MD, PhD, discusses her presentation on the anatomical…

Lineage Cell Therapeutics’ Vision Restoration Program awarded NIH grant

August 15, 2019
Lineage Cell Therapeutics has received a $670,621 Small Business Innovation Research grant from the NIH, according to a press release. The funds are…

Meeting NewsVideo

VIDEO: Bi-Blade efficiency compares favorably with single port cutter

August 15, 2019
CHICAGO — At the American Society of Retina Specialists meeting, Kevin Blinder, MD, discusses his poster presentation comparing the clinical…


BLOG: What's the next fluorescein angiography?

August 14, 2019
I was recently reading an interesting article from 2011 describing the story of how fluorescein angiography was brought to our field by a couple of…

Grants awarded to NEI researchers

August 14, 2019
Two National Eye Institute scientists were awarded grants from the Knights Templar Eye Foundation to research inherited retinal degenerations…

FDA approves Eylea prefilled syringe

August 13, 2019
The FDA has approved a chemistry, manufacturing and controls prior-approval supplement for the Eylea injection prefilled syringe, Regeneron announced…

Systems biology approach needed for dry AMD research

August 12, 2019
Finding treatments for dry age-related macular degeneration requires a large-scale, collaborative, systems biology approach. Dry AMD, which…


BLOG: Applying risk management to clinical practice

August 12, 2019
Risk assessment and risk management are common tools in modern society. Although the concept can be traced back to the ancient Greeks from around 400…

ProQR’s retinitis pigmentosa candidate gets investigational NDA clearance

August 12, 2019
The FDA has cleared an investigational new drug application for QR-1123, an investigational oligonucleotide treatment candidate for vision loss with…

Meeting News

Real-world rates of suspected endophthalmitis after injections similar to clinical trial rates

August 9, 2019
CHICAGO — In a large retrospective review of real-world rates of endophthalmitis after intravitreal anti-VEGF and steroid injections, rates…

Regenxbio’s wet AMD gene therapy shows positive phase 1/2a results

August 8, 2019
RGX-314, Regenxbio’s gene therapy using NAV vectors for AAV-mediated antibody delivery, has shown positive phase 1/2a results in patients with…

Meeting News

Geographic atrophy progression mostly unchanged with treat-and-extend ranibizumab for wet AMD

August 7, 2019
CHICAGO — A 24-month treat-and-extend analysis trial with ranibizumab for patients with neovascular age-related macular degeneration showed the…

CHMP recommends Lucentis approval for ROP in Europe

August 7, 2019
Lucentis has been recommended for approval for the treatment of retinopathy of prematurity in preterm infants by the European Medicines…

EMA validates abicipar marketing authorization application

August 6, 2019
The European Medicines Agency has validated the marketing authorization application for abicipar, Molecular Partners announced. If approved…